Introduce the details
Raw materials division plant
- Categories:API production base
- Time of issue:2020-09-16 22:41:33
The company’s API plant is located in Nanjing Chemical Industrial Park, covering an area of 45 acres. It has 4 production workshops and can produce more than 10 products such as levamisole hydrochloride, ketoconazole, calcium ketoate, and chloramphenicol according to market demand. The annual production capacity is more than 1,000 tons. The production facilities, process layout, purified water and purification system of the plant are all at the leading level of similar enterprises.
The company has been producing APIs for more than 40 years, and the production process is mature and stable. Since the restructuring, with the strategy of “refining superior raw materials and focusing on the development of characteristic raw materials”, it has strengthened internal management and focused on external cooperation. Currently, there are 15 new raw materials under development.
In order to improve the comprehensive level of API production management and prove that the company has the ability to provide high-quality products and deliver APIs to the US market, in 2008, the company decided to invest in the construction of high-end API workshops in accordance with FDA hardware standards, and completed the investment in 2009 Production of levamisole hydrochloride products. In 2011, it received on-site audit by the FDA for the first time and was listed as an "acceptable" level. In September 2014, Levamisole Hydrochloride passed the European CEP certification, successfully expanding the European high-end market, and obtained the US FDA site in April 2015 According to the audit’s written approval, the levamisole product has been approved for legal sales in relevant controlled industries in the United States.
In terms of safety and environmental protection in the production of APIs, the company has made the oath of "I would rather stop production than do it, and never pollute people". It aims to be a leader in environmental protection. Since 2009, it has invested more than 18 million yuan in construction and transformation of environmental protection. Facilities, environmental protection operating costs more than 20 million yuan, advanced sewage and waste gas treatment equipment, has been repeatedly awarded by the Municipal Environmental Protection Bureau.
Levamisole hydrochloride products produced by the company account for more than 50% of the global market share; ketoconazole production and sales are leading domestically, accounting for more than 60% of the domestic market share. Through multi-channel cooperation, the company will closely follow the development trends of the international pharmaceutical industry, seize more opportunities and achieve better development.
Address: 8/F, Jinying Hanzhong New City, No.1, Hanzhongmen Street, Jianye District, Nanjing
Tel: Switchboard: +86-25-86612898 Domestic Trade Department: +86-25-86504316
International Trade Department: +86-25-86536211 Customer Service: +86-25-86504315
Nanjing BAIJINGYU Pharmaceutical Co., Ltd. Su ICP No. 05021313 -1 | comments powered by www.300.cn